Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 21,416 | 12,637 | 13,077 | 11,812 | 8,253 |
| Gross Profit | 21,416 | 12,637 | 13,077 | 11,812 | 8,253 |
| Operating Expenses | 40,556 | 33,634 | 26,843 | 24,847 | 21,021 |
| Operating Income | -19,140 | -20,997 | -13,766 | -13,035 | -12,768 |
| Other Income | 2,500 | 810 | 675 | 681 | 277 |
| Pre-tax Income | -16,640 | -20,187 | -13,091 | -12,354 | -12,491 |
| Net Income Continuous | -16,640 | -20,187 | -13,091 | -12,354 | -12,491 |
| Net Income | $-16,640 | $-20,187 | $-13,091 | $-12,354 | $-12,491 |
| EPS Basic Total Ops | -0.17 | -0.23 | -0.15 | -0.15 | -0.17 |
| EPS Basic Continuous Ops | -0.17 | -0.23 | -0.14 | -0.15 | -0.17 |
| EPS Diluted Total Ops | -0.17 | -0.23 | -0.15 | -0.15 | -0.17 |
| EPS Diluted Continuous Ops | -0.17 | -0.23 | -0.14 | -0.15 | -0.17 |
| EBITDA(a) | $-19,718 | $-20,868 | $-13,661 | $-12,965 | $-12,479 |